Physician profile
Ramesh Chandra
NPI 1326318130
$6,749.36
in general payments reported to CMS, 2019-2025
33 companies · $775 in 2025
The $775 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,673 · 2020: $419 · 2021: $431 · 2022: $204 · 2023: $168 · 2024: $2,079 · 2025: $775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,860 · Travel and Lodging: $1,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,860.00 |
| Travel and Lodging | $1,162.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,999.14 | 2019-2024 | Optis, Coroflow |
| Medtronic Vascular, INC. | $1,004.76 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $520.90 | 2019-2025 | Lifevest |
| Biocompatibles, INC. | $503.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $308.08 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $288.12 | 2019-2022 | |
| Abiomed | $284.96 | 2022-2025 | Impella |
| Boston Scientific Corporation | $277.24 | 2019-2025 | General - Stents, Synergy |
| Medtronic, INC. | $221.91 | 2021-2025 | Symplicity G3, Linq II |
| Amgen INC. | $217.98 | 2019-2021 | |
| Inspire Medical Systems, INC. | $158.36 | 2025 | Inspire |
| Shockwave Medical, INC | $137.54 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $130.03 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $91.70 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $85.79 | 2025 | Assure Wcd |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $76.58 | 2019 | |
| Angiodynamics, INC. | $64.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.24 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $53.57 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $40.07 | 2019-2021 | |
| Amarin Pharma, INC. | $36.98 | 2019 | |
| Ekos Corporation | $32.67 | 2019 | |
| Vifor Pharma, INC. | $29.19 | 2019 | |
| Intact Vascular, INC. | $16.30 | 2019 | |
| Novo Nordisk INC | $16.14 | 2019 | |
| Daiichi Sankyo INC. | $14.26 | 2021 | |
| Lundbeck LLC | $13.04 | 2019 | |
| Philips North America LLC | $12.60 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.50 | 2019 | |
| Biotronik INC. | $11.42 | 2019 | |
| Glaxosmithkline, LLC. | $11.09 | 2020 | |
| Shire North American Group INC | $11.04 | 2019 | |
| Circassia INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Chandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.